AT
ADVAC Therapeutics Inc
SEC filingPharmaceuticals · Columus, OH
Amount raised$500Ksold at filing
Total offering$5M$4.5M still open
Investors in the raise1count reported to the SEC
FiledMar 10, 2026first sale Feb 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark Walter GossettExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.